$KPTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Karyopharm Therapeutics Inc.. Get notifications about new insider transactions in Karyopharm Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 25 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 41.29 | 42,800 | 1,767,144 | 9,610,815 | 9.7 M to 9.6 M (-0.44 %) |
Nov 21 2014 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, WW Development ... | Option Exercise | A | 39.95 | 160,000 | 6,392,000 | 160,000 | |
Nov 20 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 40.01 | 60,268 | 2,411,021 | 9,653,615 | 9.7 M to 9.7 M (-0.62 %) |
Nov 20 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 41.01 | 5,700 | 233,770 | 9,713,883 | 9.7 M to 9.7 M (-0.06 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 43.19 | 6,200 | 267,764 | 9,586,883 | 9.6 M to 9.6 M (-0.06 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.26 | 38,800 | 1,639,583 | 9,593,083 | 9.6 M to 9.6 M (-0.40 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.51 | 54,100 | 2,299,878 | 9,631,883 | 9.7 M to 9.6 M (-0.56 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 45.49 | 200 | 9,098 | 9,685,983 | 9.7 M to 9.7 M (0.00 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 44.73 | 10,300 | 460,763 | 9,686,183 | 9.7 M to 9.7 M (-0.11 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 43.80 | 23,100 | 1,011,743 | 9,696,483 | 9.7 M to 9.7 M (-0.24 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.65 | 31,400 | 1,339,197 | 9,719,583 | 9.8 M to 9.7 M (-0.32 %) |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Garland J. Scott | Director | Option Exercise | A | 43.30 | 20,000 | 866,000 | 20,000 | |
Nov 12 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 45.05 | 5,000 | 225,256 | 7,727 | 12.7 K to 7.7 K (-39.29 %) |
Nov 05 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 40.95 | 5,000 | 204,751 | 12,727 | 17.7 K to 12.7 K (-28.21 %) |
Nov 06 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 43.74 | 1,400 | 61,240 | 9,750,983 | 9.8 M to 9.8 M (-0.01 %) |
Nov 06 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 43.19 | 66,650 | 2,878,713 | 9,752,383 | 9.8 M to 9.8 M (-0.68 %) |
Nov 06 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.02 | 107,934 | 4,535,862 | 9,819,033 | 9.9 M to 9.8 M (-1.09 %) |
Nov 06 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.55 | 5,700 | 242,531 | 9,926,967 | 9.9 M to 9.9 M (-0.06 %) |
Nov 06 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 41.38 | 91,100 | 3,769,818 | 9,932,667 | 10 M to 9.9 M (-0.91 %) |
Oct 31 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 40.05 | 3,500 | 140,161 | 17,727 | 21.2 K to 17.7 K (-16.49 %) |
Oct 22 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 35.04 | 1,500 | 52,560 | 21,227 | 22.7 K to 21.2 K (-6.60 %) |
Sep 30 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 43.16 | 50,551 | 2,181,609 | 10,023,767 | 10.1 M to 10 M (-0.50 %) |
Sep 30 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.47 | 149,449 | 6,347,592 | 10,074,318 | 10.2 M to 10.1 M (-1.46 %) |
Sep 30 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 44.00 | 200 | 8,800 | 2,850,517 | 2.9 M to 2.9 M (-0.01 %) |
Sep 30 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 43.39 | 12,261 | 531,973 | 2,850,717 | 2.9 M to 2.9 M (-0.43 %) |
Sep 30 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 42.44 | 25,059 | 1,063,589 | 2,862,978 | 2.9 M to 2.9 M (-0.87 %) |
Sep 30 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 41.89 | 12,480 | 522,838 | 2,888,037 | 2.9 M to 2.9 M (-0.43 %) |
Sep 26 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 40.32 | 22,498 | 907,133 | 2,900,517 | 2.9 M to 2.9 M (-0.77 %) |
Sep 19 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 40.16 | 2,778 | 111,556 | 2,923,015 | 2.9 M to 2.9 M (-0.09 %) |
Sep 19 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 40.26 | 9,569 | 385,270 | 2,925,793 | 2.9 M to 2.9 M (-0.33 %) |
Sep 16 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 41.12 | 4,312 | 177,325 | 10,223,767 | 10.2 M to 10.2 M (-0.04 %) |
Sep 15 2014 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Option Exercise | A | 40.95 | 245,000 | 10,032,750 | 245,000 | |
Sep 10 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 39.92 | 35,666 | 1,423,623 | 2,935,692 | 3 M to 2.9 M (-1.20 %) |
Sep 08 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 38.07 | 12,795 | 487,095 | 2,971,358 | 3 M to 3 M (-0.43 %) |
Aug 28 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 39.07 | 21,460 | 838,431 | 2,984,153 | 3 M to 3 M (-0.71 %) |
Aug 28 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 39.09 | 1,846 | 72,165 | 3,005,613 | 3 M to 3 M (-0.06 %) |
Aug 28 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 38.50 | 20,393 | 785,139 | 3,007,459 | 3 M to 3 M (-0.67 %) |
Aug 27 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 38.08 | 4,389 | 167,151 | 3,027,852 | 3 M to 3 M (-0.14 %) |
Aug 21 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 39.10 | 3,175 | 124,132 | 3,032,241 | 3 M to 3 M (-0.10 %) |
Aug 18 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 39.14 | 7,827 | 306,359 | 3,035,416 | 3 M to 3 M (-0.26 %) |
Aug 18 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 38.04 | 200 | 7,609 | 3,043,243 | 3 M to 3 M (-0.01 %) |
Aug 13 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 37.30 | 36,979 | 1,379,350 | 3,043,443 | 3.1 M to 3 M (-1.20 %) |
Aug 07 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 37.13 | 41,481 | 1,540,115 | 3,080,422 | 3.1 M to 3.1 M (-1.33 %) |
Aug 01 2014 | KPTI | Karyopharm Therape ... | Czernik Marcin | 10% Owner | Sell | S | 36.20 | 21,570 | 780,931 | 3,121,903 | 3.1 M to 3.1 M (-0.69 %) |
Jul 31 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 35.20 | 30,000 | 1,055,853 | 10,228,079 | 10.3 M to 10.2 M (-0.29 %) |
Jul 25 2014 | KPTI | Karyopharm Therape ... | Plio Ltd | 10% Owner | Buy | S | 35.54 | 500,000 | 17,771,850 | 2,693,473 | 2.2 M to 2.7 M (+22.79 %) |
Jul 09 2014 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 36.04 | 10,000 | 360,400 | 10,000 | |
Jul 09 2014 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Option Exercise | A | 36.04 | 10,000 | 360,400 | 10,000 | |
Jul 09 2014 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | A | 36.04 | 10,000 | 360,400 | 10,000 | |
Jul 09 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 36.04 | 10,000 | 360,400 | 10,000 | |
Jul 09 2014 | KPTI | Karyopharm Therape ... | WEG KENNETH E | Director | Option Exercise | A | 36.04 | 10,000 | 360,400 | 10,000 | |
Jul 02 2014 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 42.50 | 100,000 | 4,250,000 | 587,596 | 687.6 K to 587.6 K (-14.54 %) |
Jul 02 2014 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 42.50 | 100,000 | 4,250,000 | 808,963 | 909 K to 809 K (-11.00 %) |
Jul 02 2014 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 42.50 | 100,000 | 4,250,000 | 808,963 | 909 K to 809 K (-11.00 %) |
Jul 02 2014 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 42.50 | 100,000 | 4,250,000 | 587,596 | 687.6 K to 587.6 K (-14.54 %) |
Jun 19 2014 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 43.15 | 10,000 | 431,523 | 687,596 | 697.6 K to 687.6 K (-1.43 %) |
Jun 19 2014 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 40.36 | 10,000 | 403,635 | 908,963 | 919 K to 909 K (-1.09 %) |
Jun 19 2014 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 40.36 | 10,000 | 403,635 | 908,963 | 919 K to 909 K (-1.09 %) |
Jun 19 2014 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 43.15 | 10,000 | 431,523 | 687,596 | 697.6 K to 687.6 K (-1.43 %) |
May 23 2014 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 26.45 | 17 | 450 | 21,443 | 21.4 K to 21.4 K (+0.08 %) |
May 23 2014 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 26.45 | 1,752 | 46,334 | 2,196,109 | 2.2 M to 2.2 M (+0.08 %) |
May 23 2014 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 26.09 | 193 | 5,035 | 21,426 | 21.2 K to 21.4 K (+0.91 %) |
May 23 2014 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 26.09 | 19,807 | 516,769 | 2,194,357 | 2.2 M to 2.2 M (+0.91 %) |
May 23 2014 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 26.19 | 896 | 23,470 | 21,233 | 20.3 K to 21.2 K (+4.41 %) |
May 23 2014 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 26.19 | 91,754 | 2,403,404 | 2,174,550 | 2.1 M to 2.2 M (+4.41 %) |
May 15 2014 | KPTI | Karyopharm Therape ... | Brannelly Paul | SVP, FINANCE & ADMI ... | Buy | P | 25.95 | 700 | 18,165 | 66,136 | 65.4 K to 66.1 K (+1.07 %) |
May 14 2014 | KPTI | Karyopharm Therape ... | Brannelly Paul | SVP, FINANCE & ADMI ... | Buy | P | 26.93 | 800 | 21,544 | 65,436 | 64.6 K to 65.4 K (+1.24 %) |
May 13 2014 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | VP, GEN COUNSEL & S ... | Buy | P | 26.75 | 1,000 | 26,750 | 1,000 | 0 to 1,000 |
May 13 2014 | KPTI | Karyopharm Therape ... | Brannelly Paul | SVP, FINANCE & ADMI ... | Buy | P | 28.06 | 1,000 | 28,057 | 64,636 | 63.6 K to 64.6 K (+1.57 %) |
Apr 17 2014 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | V.P., Gen. Counsel ... | Option Exercise | A | 32.40 | 75,000 | 2,430,000 | 75,000 | |
Dec 20 2013 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 23.66 | 140,000 | 3,312,400 | 140,000 | |
Dec 20 2013 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 23.66 | 140,000 | 3,312,400 | 140,000 | |
Dec 20 2013 | KPTI | Karyopharm Therape ... | Shacham Sharon | Pres. & Chief Scien ... | Option Exercise | A | 23.66 | 140,000 | 3,312,400 | 140,000 | |
Dec 20 2013 | KPTI | Karyopharm Therape ... | Shacham Sharon | Pres. & Chief Scien ... | Option Exercise | A | 23.66 | 140,000 | 3,312,400 | 140,000 | |
Dec 20 2013 | KPTI | Karyopharm Therape ... | Brannelly Paul | SVP, FIN & ADMIN, S ... | Option Exercise | A | 23.66 | 46,000 | 1,088,360 | 46,000 | |
Dec 20 2013 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 23.66 | 15,000 | 354,900 | 15,000 | |
Dec 09 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 16.03 | 20,000 | 320,600 | 20,000 | |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Option Exercise | C | 0.00 | 6,000,000 | 0 | 0 | |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Option Exercise | C | 0.00 | 1,764,706 | 0 | 0 | |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Option Exercise | C | 0.00 | 6,086,957 | 0 | 0 | |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Buy | C | 0.00 | 10,258,079 | 0 | 10,258,079 | 0 to 10.3 M |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Buy | C | 0.00 | 10,258,079 | 0 | 10,258,079 | 0 to 10.3 M |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Plio Ltd | 10% Owner | Option Exercise | C | 0.00 | 9,000,000 | 0 | 0 | |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Plio Ltd | 10% Owner | Option Exercise | C | 0.00 | 1,538,461 | 0 | 0 | |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Plio Ltd | 10% Owner | Buy | C | 0.00 | 3,193,473 | 0 | 3,193,473 | 0 to 3.2 M |
Nov 15 2013 | KPTI | Karyopharm Therape ... | Plio Ltd | 10% Owner | Buy | C | 0.00 | 3,193,473 | 0 | 3,193,473 | 0 to 3.2 M |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | C | 0.00 | 2,663 | 0 | 0 | |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | C | 0.00 | 272,818 | 0 | 0 | |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | C | 0.00 | 14,652 | 0 | 0 | |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | C | 0.00 | 1,500,500 | 0 | 0 | |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 16.00 | 3,022 | 48,352 | 20,337 | 17.3 K to 20.3 K (+17.45 %) |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 16.00 | 309,478 | 4,951,648 | 2,082,796 | 1.8 M to 2.1 M (+17.45 %) |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | C | 0.00 | 17,315 | 0 | 17,315 | 0 to 17.3 K |
Nov 14 2013 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | C | 0.00 | 1,773,318 | 0 | 1,773,318 | 0 to 1.8 M |
Nov 13 2013 | KPTI | Karyopharm Therape ... | Shacham Sharon | CSO & Pres. Res. & ... | Option Exercise | C | 0.00 | 132,575 | 0 | 0 | |
Nov 13 2013 | KPTI | Karyopharm Therape ... | Shacham Sharon | CSO & Pres. Res. & ... | Buy | C | 0.00 | 132,575 | 0 | 753,346 | 620.8 K to 753.3 K (+21.36 %) |
Nov 13 2013 | KPTI | Karyopharm Therape ... | Kauffman Michael | President, CEO & CM ... | Option Exercise | C | 0.00 | 132,575 | 0 | 0 | |
Nov 13 2013 | KPTI | Karyopharm Therape ... | Kauffman Michael | President, CEO & CM ... | Buy | C | 0.00 | 132,575 | 0 | 753,346 | 620.8 K to 753.3 K (+21.36 %) |